{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:54:04Z","timestamp":1781661244111,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06212-2","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:06:06Z","timestamp":1777478766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-endoglin monoclonal antibody TRC105 prevents the increase of liver inflammatory biomarkers in a mouse model of cholestasis"],"prefix":"10.1007","volume":"83","author":[{"given":"Samira","family":"Eissazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Nemeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Fikrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana Urbankova","family":"Rathouska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vasinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Niloufar","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Tripska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Hroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Micuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Nachtigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"6212_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","volume":"339","author":"M Trauner","year":"1998","unstructured":"Trauner M, Meier PJ, Boyer JL (1998) Molecular pathogenesis of cholestasis. N Engl J Med 339:1217\u20131227","journal-title":"N Engl J Med"},{"key":"6212_CR2","unstructured":"Sherlock S, Dooley JS (2008) Diseases of the liver and biliary system. Wiley"},{"key":"6212_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633\u2013671","journal-title":"Physiol Rev"},{"key":"6212_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","volume":"129","author":"A dela Pe\u00f1a","year":"2005","unstructured":"dela Pe\u00f1a A, Leclercq I, Field J, George J, Jones B, Farrell G (2005) NF-\u03baB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129:1663\u20131674","journal-title":"Gastroenterology"},{"key":"6212_CR5","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1096\/fj.201701536R","volume":"32","author":"L Zhong","year":"2018","unstructured":"Zhong L, Simard MJ, Huot J (2018) Endothelial microRNAs regulating the NF-\u03baB pathway and cell adhesion molecules during inflammation. FASEB J 32:4070\u20134084","journal-title":"FASEB J"},{"key":"6212_CR6","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms21145097","volume":"21","author":"A Arsenijevic","year":"2020","unstructured":"Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M (2020) Galectin-3 in inflammasome activation and primary biliary cholangitis development. Int J Mol Sci 21:5097","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6212_CR7","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00018-020-03701-w","volume":"78","author":"M Vicen","year":"2020","unstructured":"Vicen M, Igreja Sa IC, Tripska K, Vitverova B, Najmanova I, Eissazadeh S, Micuda S, Nachtigal P (2020) Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome. Cell Mol Life Sci 78(6):2405\u20132418","journal-title":"Cell Mol Life Sci"},{"key":"6212_CR8","doi-asserted-by":"publisher","first-page":"166990","DOI":"10.1016\/j.bbadis.2023.166990","volume":"1870","author":"S Eissazadeh","year":"2024","unstructured":"Eissazadeh S, Mohammadi S, Faradonbeh FA, Rathouska JU, Nemeckova I, Tripska K, Vitverova B, Dohnalkova E, Vasinova M, Fikrova P, Sa ICI, Micuda S, Nachtigal P (2024) Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo. Biochim Biophys Acta Mol Basis Dis 1870:166990","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6212_CR9","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1210\/endo.134.6.8194490","volume":"134","author":"S St-Jacques","year":"1994","unstructured":"St-Jacques S, Cymerman U, Pece N, Letarte M (1994) Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology 134:2645\u20132657","journal-title":"Endocrinology"},{"key":"6212_CR10","doi-asserted-by":"crossref","unstructured":"Meurer S, Wimmer AE, Leur EV, Weiskirchen R (2019) Endoglin Trafficking\/Exosomal Targeting in Liver Cells Depends on N-Glycosylation. Cells 8(9):997","DOI":"10.3390\/cells8090997"},{"key":"6212_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/eji.1830220216","volume":"22","author":"P Lastres","year":"1992","unstructured":"Lastres P, Bellon T, Cabanas C, Sanchez-Madrid F, Acevedo A, Gougos A, Letarte M, Bernabeu C (1992) Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 22:393\u2013397","journal-title":"Eur J Immunol"},{"key":"6212_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4331\/wjbc.v5.i2.180","volume":"5","author":"SK Meurer","year":"2014","unstructured":"Meurer SK, Alsamman M, Scholten D, Weiskirchen R (2014) Endoglin in liver fibrogenesis: Bridging basic science and clinical practice. World J Biol Chem 5:180\u2013203","journal-title":"World J Biol Chem"},{"key":"6212_CR13","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","volume":"23","author":"F Lebrin","year":"2004","unstructured":"Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, and, Dijke P (2004) Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction. EMBO J 23:4018\u20134028","journal-title":"EMBO J"},{"key":"6212_CR14","doi-asserted-by":"crossref","unstructured":"Gadomski S, Singh SK, Singh S, Sarkar T, Klarmann KD, Berenschot M, Seaman S, Jakubison B, Gudmundsson KO, Lockett S (2020) Id1 and Id3 maintain steady-state hematopoiesis by promoting sinusoidal endothelial cell survival and regeneration. Cell reports 31","DOI":"10.1016\/j.celrep.2020.107572"},{"key":"6212_CR15","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.ajpath.2015.07.005","volume":"185","author":"N Zhang","year":"2015","unstructured":"Zhang N, Subbaramaiah K, Yantiss RK, Zhou XK, Chin Y, Scherl EJ, Bosworth BP, Benezra R, Dannenberg AJ (2015) Id1 expression in endothelial cells of the colon is required for normal response to injury. Am J Pathol 185:2983\u20132993","journal-title":"Am J Pathol"},{"key":"6212_CR16","doi-asserted-by":"crossref","unstructured":"Herrera B, Addante A, S\u00e1nchez A (2017) BMP Signalling at the crossroad of liver fibrosis and regeneration. Int J Mol Sci 19(1):39","DOI":"10.3390\/ijms19010039"},{"key":"6212_CR17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/hep.21135","volume":"43","author":"E Wiercinska","year":"2006","unstructured":"Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, Gressner A, Thorikay M, ten Dijke P, Mertens PR, Breitkopf K (2006) Id1 is a critical mediator in TGF-\u03b2\u2013induced transdifferentiation of rat hepatic stellate cells. Hepatology 43:1032\u20131041","journal-title":"Hepatology"},{"key":"6212_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/febs.13665","volume":"283","author":"I Fabregat","year":"2016","unstructured":"Fabregat I, Moreno-C\u00e0ceres J, S\u00e1nchez A, Dooley S, Dewidar B, Giannelli G, Dijke T, P (2016) TGF-\u03b2 signalling and liver disease. Febs j 283:2219\u20132232","journal-title":"Febs j"},{"key":"6212_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","volume":"347","author":"S Dooley","year":"2012","unstructured":"Dooley S, ten Dijke P (2012) TGF-\u03b2 in progression of liver disease. Cell Tissue Res 347:245\u2013256","journal-title":"Cell Tissue Res"},{"key":"6212_CR20","doi-asserted-by":"crossref","unstructured":"Hu J, Liu Y, Pan Z, Huang X, Wang J, Cao W, Chen Z (2023) Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing \u03b2-catenin\/PAI-1 Pathway. Int J Mol Sci 24(6):5933","DOI":"10.3390\/ijms24065933"},{"key":"6212_CR21","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.2741\/2285","volume":"12","author":"Y Aso","year":"2007","unstructured":"Aso Y (2007) Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 12:2957\u20132966","journal-title":"Front Biosci"},{"key":"6212_CR22","doi-asserted-by":"publisher","first-page":"123428","DOI":"10.1016\/j.lfs.2025.123428","volume":"364","author":"S Eissazadeh","year":"2025","unstructured":"Eissazadeh S, Fikrova P, Rathouska JU, Nemeckova I, Tripska K, Vasinova M, Havelek R, Mohammadi S, Sa I, Theuer IC, Konig C, Micuda M, S., and, Nachtigal P (2025) Anti-Endoglin monoclonal antibody prevents the progression of liver sinusoidal endothelial inflammation and fibrosis in MASH. Life Sci 364:123428","journal-title":"Life Sci"},{"key":"6212_CR23","doi-asserted-by":"publisher","first-page":"1116422","DOI":"10.3389\/fphar.2023.1116422","volume":"14","author":"CI Sa","year":"2023","unstructured":"Sa CI, Tripska I, Alaei Faradonbeh K, Hroch F, Lastuvkova M, Schreiberova H, Kacerovsky J, Pericacho M, Nachtigal M, P., and, Micuda S (2023) Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis. Front Pharmacol 14:1116422","journal-title":"Front Pharmacol"},{"key":"6212_CR24","doi-asserted-by":"crossref","unstructured":"Park ES, Kim S, Yao DC, Savarraj JPJ, Choi HA, Chen PR, Kim E (2022) Soluble endoglin stimulates inflammatory and angiogenic responses in microglia that are associated with endothelial dysfunction. Int J Mol Sci 23(3):1225","DOI":"10.3390\/ijms23031225"},{"key":"6212_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lfs.2017.03.014","volume":"175","author":"M Varejckova","year":"2017","unstructured":"Varejckova M, Gallardo-Vara E, Vicen M, Vitverova B, Fikrova P, Dolezelova E, Rathouska J, Prasnicka A, Blazickova K, Micuda S, Bernabeu C, Nemeckova I, Nachtigal P (2017) Soluble endoglin modulates the pro-inflammatory mediators NF-kappaB and IL-6 in cultured human endothelial cells. Life Sci 175:52\u201360","journal-title":"Life Sci"},{"key":"6212_CR26","doi-asserted-by":"publisher","first-page":"e50920","DOI":"10.1371\/journal.pone.0050920","volume":"7","author":"O Nolan-Stevaux","year":"2012","unstructured":"Nolan-Stevaux O, Zhong W, Culp S, Shaffer K, Hoover J, Wickramasinghe D, Ruefli-Brasse A (2012) Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies. PLoS ONE 7:e50920","journal-title":"PLoS ONE"},{"key":"6212_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10637-014-0129-y","volume":"32","author":"Y Liu","year":"2014","unstructured":"Liu Y, Tian H, Blobe GC, Theuer CP, Hurwitz HI, Nixon AB (2014) Effects of the combination of TRC105 and bevacizumab on endothelial cell biology. Invest New Drugs 32:851\u2013859","journal-title":"Invest New Drugs"},{"key":"6212_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/cam4.207","volume":"3","author":"Y Liu","year":"2014","unstructured":"Liu Y, Starr MD, Brady JC, Dellinger A, Pang H, Adams B, Theuer CP, Lee NY, Hurwitz HI, Nixon AB (2014) Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer. Cancer Med 3:580\u2013591","journal-title":"Cancer Med"},{"key":"6212_CR29","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-12-0098","volume":"18","author":"LS Rosen","year":"2012","unstructured":"Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS (2012) A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin Cancer Res 18:4820\u20134829","journal-title":"Clin Cancer Res"},{"key":"6212_CR30","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/onc.2013.386","volume":"33","author":"S Kumar","year":"2014","unstructured":"Kumar S, Pan CC, Bloodworth JC, Nixon AB, Theuer C, Hoyt DG, Lee NY (2014) Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-beta signaling. Oncogene 33:3970\u20133979","journal-title":"Oncogene"},{"key":"6212_CR31","doi-asserted-by":"crossref","unstructured":"Pose E, Sancho-Bru P, Coll M (2019) 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research. Methods Mol Biol 1981, 249\u2013257","DOI":"10.1007\/978-1-4939-9420-5_16"},{"key":"6212_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2015.03.040","volume":"759","author":"ML Graham","year":"2015","unstructured":"Graham ML, Prescott MJ (2015) The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease. Eur J Pharmacol 759:19\u201329","journal-title":"Eur J Pharmacol"},{"key":"6212_CR33","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/j.1440-1746.2011.06748.x","volume":"26","author":"G Kolouchova","year":"2011","unstructured":"Kolouchova G, Brcakova E, Hirsova P, Sispera L, Tomsik P, Cermanova J, Hyspler R, Slanarova M, Fuksa L, Lotkova H (2011) Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis. J Gastroenterol Hepatol 26:1544\u20131551","journal-title":"J Gastroenterol Hepatol"},{"key":"6212_CR34","doi-asserted-by":"publisher","first-page":"38066","DOI":"10.1038\/s41598-025-21972-w","volume":"15","author":"S Eissazadeh","year":"2025","unstructured":"Eissazadeh S, Rathouska JU, Nemeckova I, Fikrova P, Tripska K, Vasinova M, Kolackova M, Nachtigal P (2025) Cost-effective method for semi-quantitative analysis of soluble endoglin in biological samples after anti-endoglin monoclonal antibody treatment. Sci Rep 15:38066","journal-title":"Sci Rep"},{"key":"6212_CR35","doi-asserted-by":"crossref","unstructured":"Lastuvkova H, Dohnalkova E, Manna DF, Cermanova J, Mokry J, Pejchal J, Hirsova P, Nachtigal P, Pavkova I, Bajnokova M, Smutna L, Stefela A, Kamaraj R, Jandova L, Uher M, Pavek P, Micuda S, Hroch M (2025) Dimethyl fumarate attenuates bile acid retention and liver fibrosis in a mouse model of cholestasis. Am J Physiol gastrointest liver physiol","DOI":"10.1152\/ajpgi.00262.2024"},{"key":"6212_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/liv.14800","volume":"41","author":"E Gijbels","year":"2021","unstructured":"Gijbels E, Pieters A, De Muynck K, Vinken M, Devisscher L (2021) Rodent models of cholestatic liver disease: A practical guide for translational research. Liver Int 41:656\u2013682","journal-title":"Liver Int"},{"key":"6212_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","volume":"171","author":"P Fickert","year":"2007","unstructured":"Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M (2007) A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171:525\u2013536","journal-title":"Am J Pathol"},{"key":"6212_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12079-011-0154-y","volume":"6","author":"KW Finnson","year":"2012","unstructured":"Finnson KW, Philip A (2012) Endoglin in liver fibrosis. J Cell Commun Signal 6:1\u20134","journal-title":"J Cell Commun Signal"},{"key":"6212_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2019.04.078","volume":"707","author":"J Sun","year":"2019","unstructured":"Sun J, Wang J, Zhang N, Yang R, Chen K, Kong D (2019) Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease. Gene 707:9\u201321","journal-title":"Gene"},{"key":"6212_CR40","unstructured":"Song C-W, Qiu W, Zhou X-Q, Feng X-C, Chen W-S (2019) Elevated hepatic MDR3\/ABCB4 is directly mediated by MiR-378a-5p in human obstructive cholestasis. Eur Rev Med Pharmacol Sci 23(6):2539\u20132547"},{"key":"6212_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","volume":"75","author":"J Li","year":"2021","unstructured":"Li J, Zhu X, Zhang M, Zhang Y, Ye S, Leng Y, Yang T, Kong L, Zhang H (2021) Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. J Hepatol 75:400\u2013413","journal-title":"J Hepatol"},{"key":"6212_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/hep.28882","volume":"65","author":"L Zhang","year":"2017","unstructured":"Zhang L, Yang Z, Trottier J, Barbier O, Wang L (2017) Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay. Hepatology 65:604\u2013615","journal-title":"Hepatology"},{"key":"6212_CR43","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.celrep.2017.05.011","volume":"19","author":"T Saito","year":"2017","unstructured":"Saito T, Bokhove M, Croci R, Zamora-Caballero S, Han L, Letarte M, de Sanctis D, Jovine L (2017) Structural basis of the human endoglin-BMP9 interaction: insights into BMP signaling and HHT1. Cell Rep 19:1917\u20131928","journal-title":"Cell Rep"},{"key":"6212_CR44","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.jtha.2023.06.007","volume":"21","author":"E Rossi","year":"2023","unstructured":"Rossi E, Bernabeu C (2023) Novel vascular roles of human endoglin in pathophysiology. J Thromb Haemost 21:2327\u20132338","journal-title":"J Thromb Haemost"},{"key":"6212_CR45","doi-asserted-by":"crossref","unstructured":"Schoonderwoerd MJA, Goumans MTH, Hawinkels L (2020) Endoglin: beyond the Endothelium. Biomolecules 10","DOI":"10.3390\/biom10020289"},{"key":"6212_CR46","doi-asserted-by":"crossref","unstructured":"Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, and ten, Dijke P (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70, 4141\u20134150","DOI":"10.1158\/0008-5472.CAN-09-4466"},{"key":"6212_CR47","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/onc.2013.386","volume":"33","author":"S Kumar","year":"2014","unstructured":"Kumar S, Pan C, Bloodworth J, Nixon A, Theuer C, Hoyt D, Lee N (2014) Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-\u03b2 signaling. Oncogene 33:3970\u20133979","journal-title":"Oncogene"},{"key":"6212_CR48","first-page":"403","volume":"121","author":"E Rossi","year":"2013","unstructured":"Rossi E, Sanz-Rodriguez F, Eleno N, Duewell A, Blanco FJ, Langa C, Botella LM, Cabanas C, Lopez-Novoa JM, Bernabeu C (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood J Am Soc Hematol 121:403\u2013415","journal-title":"Blood J Am Soc Hematol"},{"key":"6212_CR49","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jtha.2023.03.023","volume":"21","author":"E Rossi","year":"2023","unstructured":"Rossi E, Pericacho M, Kauskot A, Gamella-Pozuelo L, Reboul E, Leuci A, Egido-Turrion C, El Hamaoui D, Marchelli A, Fern\u00e1ndez FJ (2023) Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with \u03b1IIb\u03b23 integrin. J Thromb Haemost 21:1943\u20131956","journal-title":"J Thromb Haemost"},{"key":"6212_CR50","doi-asserted-by":"crossref","unstructured":"Sucajtys-Szulc E, Debska-Slizien A, Rutkowski B, Szolkiewicz M, Swierczynski J, Smolenski RT (2022) Hepatocyte nuclear factor 1alpha proinflammatory effect linked to the overexpression of liver nuclear factor-kappab in experimental model of chronic kidney disease. Int J Mol Sci 23(16):8883","DOI":"10.3390\/ijms23168883"},{"key":"6212_CR51","doi-asserted-by":"publisher","first-page":"C267","DOI":"10.1152\/ajpcell.00365.2011","volume":"303","author":"X Peng","year":"2012","unstructured":"Peng X, Wang Y, Kolli S, Deng J, Li L, Wang Z, Raj JU, Gou D (2012) Physical and functional interaction between the ID1 and p65 for activation of NF-\u03baB. Am J Physiology-Cell Physiol 303:C267\u2013C277","journal-title":"Am J Physiology-Cell Physiol"},{"key":"6212_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2362.2004.01336.x","volume":"34","author":"CC Chan","year":"2004","unstructured":"Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, Hou MC, Huang HC, Lee SD (2004) Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats. Eur J Clin Invest 34:290\u2013296","journal-title":"Eur J Clin Invest"},{"key":"6212_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0168-8278(01)00045-9","volume":"34","author":"H Kojima","year":"2001","unstructured":"Kojima H, Sakurai S, Kuriyama S, Yoshiji H, Imazu H, Uemura M, Nakatani Y, Yamao J, Fukui H (2001) Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo. J Hepatol 34:805\u2013811","journal-title":"J Hepatol"},{"key":"6212_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1572-0241.2000.01684.x","volume":"95","author":"I Alam","year":"2000","unstructured":"Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC (2000) Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol 95:199\u2013203","journal-title":"Am J Gastroenterol"},{"key":"6212_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2007.07.024","volume":"162","author":"H Nagai","year":"2010","unstructured":"Nagai H, Kato A, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Furukawa K, Nozawa S, Yoshitomi H, Mitsuhashi N, Takeuchi D, Suda K, Yoshioka I, Miyazaki M (2010) Endothelin-1 aggravates hepatic ischemia\/reperfusion injury during obstructive cholestasis in bile duct ligated mice. J Surg Res 162:46\u201353","journal-title":"J Surg Res"},{"key":"6212_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcmgh.2023.06.005","volume":"16","author":"T Owen","year":"2023","unstructured":"Owen T, Carpino G, Chen L, Kundu D, Wills P, Ekser B, Onori P, Gaudio E, Alpini G, Francis H, Kennedy L (2023) Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis. Cell Mol Gastroenterol Hepatol 16:513\u2013540","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6212_CR57","doi-asserted-by":"publisher","first-page":"17900","DOI":"10.1038\/s41598-017-18094-3","volume":"7","author":"V Balasubramanian","year":"2017","unstructured":"Balasubramanian V, Mehta G, Jones H, Sharma V, Davies N, Jalan R, Mookerjee R (2017) Post-transcriptional regulation of hepatic DDAH1 with TNF blockade leads to improved eNOS function and reduced portal pressure in cirrhotic rats. Sci Rep 7:17900","journal-title":"Sci Rep"},{"key":"6212_CR58","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3389\/fimmu.2019.01309","volume":"10","author":"A Arsenijevic","year":"2019","unstructured":"Arsenijevic A, Milovanovic J, Stojanovic B, Djordjevic D, Stanojevic I, Jankovic N, Vojvodic D, Arsenijevic N, Lukic ML, Milovanovic M (2019) Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice. Front Immunol 10:1309","journal-title":"Front Immunol"},{"key":"6212_CR59","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1096\/fj.201600392RR","volume":"30","author":"J Tian","year":"2016","unstructured":"Tian J, Yang G, Chen HY, Hsu DK, Tomilov A, Olson KA, Dehnad A, Fish SR, Cortopassi G, Zhao B, Liu FT, Gershwin ME, Torok NJ, Jiang JX (2016) Galectin-3 regulates inflammasome activation in cholestatic liver injury. FASEB J 30:4202\u20134213","journal-title":"FASEB J"},{"key":"6212_CR60","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1038\/s41598-017-03956-7","volume":"7","author":"CM Lee","year":"2017","unstructured":"Lee CM, Peng HH, Yang P, Liou JT, Liao CC, Day YJ (2017) C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia\/reperfusion injury. Sci Rep 7:3698","journal-title":"Sci Rep"},{"key":"6212_CR61","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1186\/1755-1536-5-S1-S27","volume":"5","author":"F Tacke","year":"2012","unstructured":"Tacke F (2012) Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo. Fibrogenesis Tissue Repair 5:S27","journal-title":"Fibrogenesis Tissue Repair"},{"key":"6212_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"M-J Goumans","year":"2009","unstructured":"Goumans M-J, Liu Z, Ten Dijke P (2009) TGF-\u03b2 signaling in vascular biology and dysfunction. Cell Res 19:116\u2013127","journal-title":"Cell Res"},{"key":"6212_CR63","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1582-4934.2006.tb00535.x","volume":"10","author":"H Seyhan","year":"2006","unstructured":"Seyhan H, Hamzavi J, Wiercinska E, Gressner A, Mertens P, Kopp J, Horch R, Breitkopf K, Dooley S (2006) Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med 10:922\u2013932","journal-title":"J Cell Mol Med"},{"key":"6212_CR64","doi-asserted-by":"publisher","first-page":"41874","DOI":"10.1038\/srep41874","volume":"7","author":"JM Delhove","year":"2017","unstructured":"Delhove JM, Buckley SM, Perocheau DP, Karda R, Arbuthnot P, Henderson NC, Waddington SN, McKay TR (2017) Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice. Sci Rep 7:41874","journal-title":"Sci Rep"},{"key":"6212_CR65","doi-asserted-by":"publisher","first-page":"C267","DOI":"10.1152\/ajpcell.00365.2011","volume":"303","author":"X Peng","year":"2012","unstructured":"Peng X, Wang Y, Kolli S, Deng J, Li L, Wang Z, Raj JU, Gou D (2012) Physical and functional interaction between the ID1 and p65 for activation of NF-kappaB. Am J Physiol Cell Physiol 303:C267\u2013277","journal-title":"Am J Physiol Cell Physiol"},{"key":"6212_CR66","doi-asserted-by":"publisher","first-page":"845918","DOI":"10.3389\/fmed.2022.845918","volume":"9","author":"K Tripska","year":"2022","unstructured":"Tripska K, Igreja Sa IC, Vasinova M, Vicen M, Havelek R, Eissazadeh S, Svobodova Z, Vitverova B, Theuer C, Bernabeu C, Nachtigal P (2022) Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells. Front Med (Lausanne) 9:845918","journal-title":"Front Med (Lausanne)"},{"key":"6212_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/biom10020289","volume":"10","author":"MJ Schoonderwoerd","year":"2020","unstructured":"Schoonderwoerd MJ, Goumans M-JT, Hawinkels LJ (2020) Endoglin: beyond the endothelium. Biomolecules 10:289","journal-title":"Biomolecules"},{"key":"6212_CR68","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Urbani G, Distrutti E, Biagioli M (2025) Obeticholic acid and other farnesoid-X-Receptor (FXR) agonists in the treatment of liver disorders. Pharmaceuticals (Basel) 18(9):1424","DOI":"10.3390\/ph18091424"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06212-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:02:34Z","timestamp":1781658154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06212-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6212"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06212-2","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"255"}}